Afficher la couverture 'Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer : OLIGOPELVIS (GETUG-P07) | Vaugier, Loig' en grand format
/5

0 avis

Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer : OLIGOPELVIS (GETUG-P07)

Archive ouverte

Vaugier, Loig | Morvan, Cyrille | Pasquier, David | Buthaud, Xavier | Magné, Nicolas | Beckendorf, Veronique | Sargos, Paul | Crehange, Gilles | Pommier, Pascal | Loos, Genevieve | Hasbini, Ali | Latorzeff, Igor | Silva, Marlon | Paul, Julie | Blanc-Lapierre, Audrey | Supiot, Stéphane

Edité par CCSD ; Elsevier -

International audience. Androgen deprivation therapy (ADT) is a mainstay in metastatic prostate cancer, while additional salvage radiotherapy may offer prolonged remission for patients with regional node relapses. We performed an open-label, phase II trial to assess the long-term outcomes and patterns of relapse of 6-months ADT and elective pelvic radiotherapy in men with oligorecurrent (<6) pelvic nodes in prostate cancer (Oligopelvis GETUG-P07).

Consulter en ligne

Suggestions

Du même auteur

Early toxicity of a phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer (OLIGOPELVIS GETUG P07)

Archive ouverte | Vaugier, Loig | CCSD

International audience. PURPOSE:Limited pelvic nodal relapse of prostatic cancer is a paramount challenge for locoregional salvage treatments. Salvage whole pelvis radiotherapy as considered in the BLINDED trial, is...

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

Archive ouverte | Sargos, Paul | CCSD

International audience. Background: Adjuvant radiotherapy reduces the risk of biochemical progression in prostate cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early salvage radiot...

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial

Archive ouverte | Carrie, Christian | CCSD

International audience. Background: Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study,...

Chargement des enrichissements...